IP Library Granted Patent US 8,622,937
Granted Patent B2
US 8,622,937 · App. 12/247,969 · Granted Jan 7, 2014

Controlled high efficiency lesion formation using high intensity ultrasound

Inventors: Lee Weng (Bellevue, WA); David M. Perozek (Mercer Island, WA); Jimin Zhang (Bellevue, WA)
Assignee: Kona Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,622,937
App. No.
12/247,969
Granted
Jan 7, 2014
Kind
B2
Abstract

An ultrasound system used for both imaging and delivery high intensity ultrasound energy therapy to treatment sites and a method for treating tumors and other undesired tissue within a patient's body with an ultrasound device. The ultrasound device has an ultrasound transducer array disposed on a distal end of an elongate, relatively thin shaft. In one form of the invention, the transducer array is disposed within a liquid-filled elastomeric material that more effectively couples ultrasound energy into the tumor, that is directly contacted with the device. Using the device in a continuous wave mode, a necrotic zone of tissue having a desired size and shape (e.g., a necrotic volume selected to interrupt a blood supply to a tumor) can be created by controlling at least one of the f-number, duration, intensity, and direction of the ultrasound energy administered. This method speeds the therapy and avoids continuously pausing to enable intervening normal tissue to cool.

Claims (20)

1. An ultrasonic system for destroying undesired tissue at an internal site within a body of a patient, comprising:

(a) a probe that is sized to be inserted within a body of a patient;

(b) an ultrasonic transducer mounted proximate a distal end of the probe, said ultrasonic transducer being adapted to couple to a power supply to selectively energize the ultrasonic transducer so that it produces a focused beam of high intensity ultrasonic energy configured to heat tissue between the transducer and a focal point based on a combination of at least two of an f-number, an intensity, a time, and a direction of the beam of high intensity ultrasonic energy and to treat the undesired tissue at the focal point, wherein said high intensity ultrasonic energy is configured to heat tissue between the transducer and focal point to a level sufficient to cause a lesion to form between the focal point and the ultrasonic transducer and to not cause a lesion to form substantially beyond the focal point; and

(c) an ultrasound transmissive interface that is coupled to the distal end of the probe, said ultrasound transmissive interface being disposed and adapted to transmit the high intensity ultrasonic energy produced by the ultrasonic transducer into a target, said high intensity ultrasonic energy increasing a temperature of the undesired tissue.

2. The ultrasonic system of claim 1 , wherein the ultrasound transmissive interface comprises an elastomeric cavity that is adapted to contain a liquid, said elastomeric cavity being disposed between the ultrasonic transducer and a surface of a contacted tissue so that the high intensity ultrasonic energy passes through the liquid within the elastomeric cavity and into the contacted tissue.

3. The ultrasonic system of claim 2 , wherein the elastomeric cavity is formed at least in part from a semi-permeable membrane, so that the liquid from within the elastomeric cavity weeps onto a surface of the contacted tissue to increase an efficiency for coupling the high intensity ultrasonic energy into the contacted tissue.

4. The ultrasonic system of claim 2 , wherein the ultrasound transmissive interface comprises a cap made of an elastomeric material and disposed to surround the ultrasonic transducer, said cap being adapted to seal against the contacted tissue and to contain a liquid that increases an efficiency with which the high intensity ultrasonic energy is coupled into the contacted tissue.

5. The ultrasonic system of claim 4 , wherein the cap includes a rim having a double lip formed around a perimeter and includes a passage adapted to couple to a vacuum line so that the rim of the cap is held against a surface of the contacted tissue, sealing the liquid inside of the cap.

6. The ultrasonic system of claim 1 , wherein said high intensity ultrasonic energy is configured to heat tissue between the transducer and focal point to a temperature of 50° C. or more.

7. The ultrasonic system of claim 1 , wherein the lesion has a volume of about 4.5 cubic centimeters.

8. A method for administering an ultrasonic therapy to a target, comprising the steps of:

(a) providing an ultrasonic transducer that emits a focused high energy ultrasonic energy when energized;

(b) positioning the ultrasonic transducer to focus it at an imaged target;

(c) directing the ultrasonic transducer toward a desired focal point within the target;

(d) energizing the ultrasonic transducer so that it emits the focused high energy ultrasonic energy at the desired focal point, causing heating of a portion of the target disposed at the desired focal point; and

(e) controlling a combination of at least two of an f-number, an intensity, a time, and a direction of the high intensity ultrasonic energy emitted into the target without moving the focal point to cause an initial lesion to grow toward the ultrasonic transducer and in at least one other dimension and not away from the ultrasonic transducer.

9. The method of claim 8 , wherein a desired shape and size of the lesion are selected so that formation of the lesion substantially deprives the target of a blood supply, causing the ultimate destruction of the target.

10. The method of claim 8 , wherein a desired shape and size of the lesion are selected to cause heating of a blood vessel.

11. The method of claim 8 , wherein the target is a blood vessel.

12. The method of claim 8 , further comprising imaging the target.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: KONA MEDICAL, INC.
To: OTSUKA MEDICAL DEVICES CO., LTD.
Reel/Frame 052309/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2011
From: THERUS CORPORATION
To: KONA MEDICAL, INC.
Reel/Frame 025689/0494 →
Continuity (4)
Continuation 10633726 · Aug 4, 2003
Continuation 09721526 · Nov 22, 2000
Provisional Application 60167707 · Nov 26, 1999
Related Publication 20090036774A1 · Feb 5, 2009